Gluten Sensibility in Elite Athletes

NCT ID: NCT03101410

Last Updated: 2018-06-11

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 51 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2017-04-01
• Study Completion Date: 2018-03-21

Brief Summary

This clinical project aims to study the relationship between gluten consumption and its impact on digestive comfort, quality of life and performance of non-celiac athletes practicing an intensive physical activity..

Detailed Description

Gluten is a protein network that results from both, the hydration and the kneading of storage proteins contained in the endosperm of certain cereals. Gluten is particularly found in bread products but it is also found in many processed products because of its physicochemical properties (binding, swelling properties ...). This omnipresence is now blamed, and a growing percentage of the population reports "intolerance" to gluten. This gluten sensitivity hypothesis is frequently associated with intestinal disorders (irritable bowel syndrome, bloating, abdominal pain, chronic diarrhea, constipation) but also with headache, fatigue, muscle and joint aches, bone fragility, migraine, eczema, depression, anxiety .... This assumption has led to the adoption of increasingly frequent gluten-free diets among the general population, without medical justification.

Among the population, athletes are particularly concerned due to a higher prevalence of anaphylaxis dependent on the combination of physical exercise and food intake (Maulitz and Kidd syndrome). This syndrome is notably reported with consumption of cereals in particular wheat (bread, pasta). However, these conditions are poorly described with regards to gluten and scientific investigations are required to rationally characterize the benefits of gluten-free diets for elite athletes.

Therefore, this clinical project aims to study the relationship between gluten consumption and its impact on digestive comfort, quality of life and performance of non-celiac athletes practicing an intensive physical activity.

All the participants will give freely their written informed consent before their selection in the study.

Information on physical activities, demographics, anthropometrics, vital signs, relevant medical history and concomitant medication, dietary habits, usual dietary intake and nutritional supplements will be collected. All inclusion and exclusion criteria will be checked by the investigator or co-investigator.

Selected participants will be randomly allocated to treatment group (gluten or gluten free). Couple from the same family will be randomised in the same group.

After 2 months, all subjects will have the diet without gluten.

All recruited volunteers will be asked to replace their bread and pasta intake by study products (pasta and white bread with or without gluten), maintain their usual dietary habits and continue their normal physical habits.

Each 2 months, volunteers will have a physical performance assessment and will provide a blood and faeces samples. All volunteers will complete a follow-up questionnaire to obtain information about any changes in medication use, disease etc. Each week, all subjects will complete a questionnaire related to digestive function :Food Benefits Assessment (FBA)).

At the beginning and 2 months, usual dietary intakes will be estimated by means of a 3- days food records.

Conditions

Intestinal Diseases; Gluten-sensitive

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: SINGLE

Study Groups

gluten

Selected participants will be randomly allocated to treatment group (gluten or gluten free)

Group Type: EXPERIMENTAL

Gluten

Intervention Type: BEHAVIORAL

Selected participants will be randomly allocated to treatment group (gluten or gluten free).

gluten fee

Selected participants will be randomly allocated to treatment group (gluten or gluten free)

Group Type: EXPERIMENTAL

Gluten free

Intervention Type: BEHAVIORAL

Selected participants will be randomly allocated to treatment group (gluten or gluten free).

Interventions

Gluten

Selected participants will be randomly allocated to treatment group (gluten or gluten free).

Intervention Type: BEHAVIORAL

Gluten free

Selected participants will be randomly allocated to treatment group (gluten or gluten free).

Intervention Type: BEHAVIORAL

Eligibility Criteria

Inclusion Criteria

• Male and female trained >7h/week or more of 5 training/week
• Member of a sports federation or medical certificate fewer 3 months
• VO2 max estimated >125% of the theoretical value
• Regular consumption of gluten under different products
• Healthy (apparently free of diseases) and without any medical treatment
• Without digestive diseases and non-coeliac disease
• Affiliated to National Health Insurance
• Having normal capacity of training to enter in the study procedures
• Having provided her written informed consent

Exclusion Criteria

• Medicals or surgical histories, evaluated non compatible by the investigator
• Diseases known
• Antibiotherapy 2 months before the study
• Gluten-free diet
• Individual unable to give informed consent or refusing to sign informed consent
• Being in exclusion on the National Volunteers Data file or refusing to be registered on the National Volunteers Data file
• Currently participating or who having got 4500€ in this year before to have participating in another clinical trial

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Centre de Recherche en Nutrition Humaine d'Auvergne

OTHER_GOV

Sponsor Role: collaborator

Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement

OTHER

Sponsor Role: collaborator

Institut Carnot Qualiment

UNKNOWN

Sponsor Role: collaborator

University Hospital, Clermont-Ferrand

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

CHU Clermont-Ferrand

Clermont-Ferrand, , France

Countries

France

Other Identifiers

2016-A00356-45

Identifier Type: OTHER

Identifier Source: secondary_id

CHU-308

Identifier Type: -

Identifier Source: org_study_id